Lanean...
Rationale of Technical Requirements for NRG-BR001: The First NCI-Sponsored Trial of SBRT for the Treatment of Multiple Metastases
INTRODUCTION: In 2014, the NRG Oncology Group initiated the first NCI-sponsored, phase I clinical trial of SBRT for the treatment of multiple metastases in multiple organ sites (XXXX; NCTXXX). The primary endpoint is to test the safety of SBRT for the treatment of multiple lesions (2–4) in several a...
Gorde:
Argitaratua izan da: | Pract Radiat Oncol |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
2016
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099083/ https://ncbi.nlm.nih.gov/pubmed/27345129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2016.05.004 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|